Sort
53,477 grants matching “addiction”
Identification of Genetic Variants that Contribute to Compulsive Cocaine Intakein Rats
$710,355Olivier George · University Of California, San Diego · U01 · FY2022 · DA
Neural, Cognitive and Abuse-Related Consequences of Chronic THC Exposure during Adolescence in Nonhuman Primates
$710,343Jack Bergman · Mclean Hospital · R01 · FY2020 · DA
Functional and histological changes to peripheral innervation following spinal cord stimulation in patients with painful diabetic neuropathy
$710,201Kristy L Townsend · Ohio State University · R01 · FY2024 · DK
Clinical Pharmacology of Electronic Cigarettes
$710,188Neal L Benowitz · University Of California, San Francisco · R01 · FY2017 · DA
Single-cell resolution analysis of chromatin accessibility and gene expression changes in a model of drug addiction
$710,169Francesca Telese · University Of California, San Diego · U01 · FY2020 · DA
Addiction comorbidity and vulnerability
$710,117Elliot A Stein · National Institute On Drug Abuse · ZIA · FY2011 · DA
Dopaminergic Mechanisms Underlying Human Social Behavior: A Multimodal Approach
$710,087Ming Hsu · University Of California Berkeley · R01 · FY2020 · MH
Genetic Variation in Opioid Induced Respiratory Depression in Mice
$710,039Jason A Bubier · Jackson Laboratory · R01 · FY2021 · DA
A Reduced Complexity Cross in BALB/c substrains to identify the genetic basis of oxycodone dependence phenotypes
$709,989Venetia Zachariou · Boston University Medical Campus · U01 · FY2023 · DA
Intraganglionic Analgesic Adeno-Associated Virus (AAV) Gene Vector Optimization in Large Animals
$709,984Andreas S Beutler · Interventional Analgesix, Inc. · R01 · FY2021 · NS
Research Support Core
$709,948Gregory Evan Miller · University Of Georgia · P50 · FY2020 · DA
Statewide System and Organizational Strategy for Evidence-Based Practice Implementation and Sustainment in Substance Use Disorder Treatment
$709,782Gregory Aarons · University Of California, San Diego · R01 · FY2022 · DA
Self-Control Improvement Intervention (SCII): Improving Abstinence in Smokers
$709,694Warren K Bickel · Virginia Polytechnic Inst And St Univ · R01 · FY2016 · DA
The central amygdala circuits in motivated behaviors
$709,626Linda Van Aelst · Cold Spring Harbor Laboratory · R01 · FY2024 · MH
The central amygdala circuits in motivated behaviors
$709,626Linda Van Aelst · Cold Spring Harbor Laboratory · R01 · FY2023 · MH
The central amygdala circuits in motivated behaviors
$709,626Bo Li · Cold Spring Harbor Laboratory · R01 · FY2021 · MH
The central amygdala circuits in motivated behaviors
$709,626Bo Li · Cold Spring Harbor Laboratory · R01 · FY2022 · MH
Longitudinal Study of Recovery: Psychosocial Functioning, Relapse, and Neuro-Behavioral Markers
$709,584Warren K Bickel · Virginia Polytechnic Inst And St Univ · R01 · FY2023 · AA
Establishing Oprm1 exon 7-associated variants as novel therapeutic targets for mitigating adverse effects of clinically used mu opioids without altering analgesia in pain management
$709,572Ying-Xian Pan · Rutgers Biomedical And Health Sciences · R01 · FY2024 · DA
Testing Reinforcer Pathology: Mechanisms and Interventions to Change Alcohol Valuation
$709,520Warren K Bickel · Virginia Polytechnic Inst And St Univ · R01 · FY2020 · AA
An Experimental Medicine Approach for the Mechanistic Understanding of Cocaine Use Disorder: Reinforcer Pathology
$709,490Warren K Bickel · Virginia Polytechnic Inst And St Univ · R01 · FY2023 · DA
Discovery of Bifunctional NOP/Opioid Receptor Ligands for Drug Abuse Therapy
$709,446Nurulain T Zaveri · Astraea Therapeutics, Llc · R01 · FY2014 · DA
Telemedicine for Smoking Cessation in Rural Primary Care
$709,428Kimber P Richter · University Of Kansas Medical Center · R01 · FY2011 · HL
Mechanisms of maladaptive memory formation and suppression in a preclinical model of the comorbidity between PTSD and addiction
$709,324Kennon Matthew Lattal · Oregon Health & Science University · R01 · FY2019 · DA
Component 2: Administrative Core
$709,287Robert O. Messing · Ernest Gallo Clinic And Research Center · P50 · FY2012 · AA